Completed
Pilot Open Label Use of the Hi-OXSR for the Treatment of Post COVID-19 Cognitive Dysfunction
NCT06379620
- Conditions
- COVID-19, Chronic Disease, Cognition Disorders, +20 more
- Locations
-
- University Health Network Toronto, Ontario, Canada